Details

Autor(en) / Beteiligte

• Lu, Huimin
• Bowler, Nicholas
• Harshyne, Larry A.
• Craig Hooper, D.
• Krishn, Shiv Ram
• Kurtoglu, Senem
• Fedele, Carmine
• Liu, Qin
• Tang, Hsin-Yao
• Kossenkov, Andrew V.
• Kelly, William K.
• Wang, Kerith
• Kean, Rhonda B.
• Weinreb, Paul H.
• Yu, Lei
• Dutta, Anindita
• Fortina, Paolo
• Ertel, Adam
• Stanczak, Maria
• Forsberg, Flemming
• Gabrilovich, Dmitry I.
• Speicher, David W.
• Altieri, Dario C.
• Languino, Lucia R.

Titel

Exosomal αvβ6 integrin is required for monocyte M2 polarization in prostate cancer

Ist Teil von

• Matrix biology, 2018-09, Vol.70, p.20-35

Ort / Verlag

Netherlands: Elsevier B.V

Erscheinungsjahr

2018

Quelle

Alma/SFX Local Collection

Beschreibungen/Notizen

• Therapeutic approaches aimed at curing prostate cancer are only partially successful given the occurrence of highly metastatic resistant phenotypes that frequently develop in response to therapies. Recently, we have described αvβ6, a surface receptor of the integrin family as a novel therapeutic target for prostate cancer; this epithelial-specific molecule is an ideal target since, unlike other integrins, it is found in different types of cancer but not in normal tissues. We describe a novel αvβ6-mediated signaling pathway that has profound effects on the microenvironment. We show that αvβ6 is transferred from cancer cells to monocytes, including β6-null monocytes, by exosomes and that monocytes from prostate cancer patients, but not from healthy volunteers, express αvβ6. Cancer cell exosomes, purified via density gradients, promote M2 polarization, whereas αvβ6 down-regulation in exosomes inhibits M2 polarization in recipient monocytes. Also, as evaluated by our proteomic analysis, αvβ6 down-regulation causes a significant increase in donor cancer cells, and their exosomes, of two molecules that have a tumor suppressive role, STAT1 and MX1/2. Finally, using the Ptenpc−/− prostate cancer mouse model, which carries a prostate epithelial-specific Pten deletion, we demonstrate that αvβ6 inhibition in vivo causes up-regulation of STAT1 in cancer cells. Our results provide evidence of a novel mechanism that regulates M2 polarization and prostate cancer progression through transfer of αvβ6 from cancer cells to monocytes through exosomes. •This study reveals a cross-talk between cancer cells and monocytes mediated by the exosomal αvβ6.•Cancer cell exosomes promote M2 polarization.•αvβ6 down-regulation in exosomes inhibits M2 polarization in recipient monocytes.•Inhibition of αvβ6, in vitro or in vivo, causes up-regulation of STAT1 in cancer cells and exosomes.•Inhibition of αvβ6 and its effectors might offer a novel immune – based therapeutic strategy in prostate cancer.